drugset
drugset / Trial / NCT05281081

Intraperitoneal Instillation of Levobupivacaine With Morphine Versus Levobupivacaine With Magnesium Sulfate for Postoperative Analgesia

NCT05281081 ↗

Phase 4 Completed 60 enrolled Sohag University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a prospective randomized study that included 60 patients and was divided into two equal groups of patients who were scheduled for LC, Ages 18 and 60 years, both sexes, ASA I-II and BMI 19 - 39. Group A received 30 ml levobupivacaine (0.25%) plus 3 mg morphine intraperitoneal at the site of surgery in the bed of the gallbladder via the navel port with the patient in a Trendelenburg position, Group B received 30 ml levobupivacaine (0.25%) plus 50 mg/kg magnesium sulfate in the same pattern as in the A group.

Timeline

Start
2021-01-01
Primary completion
2021-08-01
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 50 mg/kg Other
Subject Morphine Other / unclassified 3 mg Other
Background Levobupivacaine Other / unclassified 0.25 % Other
Background Levobupivacaine Other / unclassified 30 ml Other

Indications

No indication recorded.